BioSpace News Archive

The innovative micro-endoscope with multiple working channels is single use, eliminating the risk of transmitting infections among patients.

Aquilion Precision the Latest System in CT Portfolio with Access to Advanced Intelligent Clear-IQ Engine (AiCE)

27th European Society of Gene and Cell Therapy (ESGCT) Congress, to be held October 22-25, 2019 in Barcelona, Spain.

Indianapolis-based medical device maker NICO Corporation continues its track record of innovation that is revolutionizing neurosurgery by introducing today at the Congress of Neurological Surgeons (CNS) its newest FDA-cleared product, the NICO Myriad NOVUS™

Capricor Therapeutics (Nasdaq: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and other rare disorders, announced today that it will host a Key Opinion Leader (KOL) call on the role of CAP-1002 in the of treatment of Duchenne Muscular Dystrophy (DMD) on Thursday, October 24th at 10:30am Eastern Time.

The Medical Device Innovation Consortium announced it has been awarded $2.8 million in funding by the U.S. Food and Drug Administration for the expansion of the Case for Quality and medical device cybersecurity programs.

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Med Center Health has signed a sole source agreement to partner with Omnicell to streamline and secure its medication management process

XLerateHealth (XLH) is pleased to announce that it was awarded Phase II funding of $1.48M, plus an Administrative Supplement of $250,000, from the National Institutes of Health (NIH) to continue building the XLerator Network, one of four Institutional Development Award (IDeA) State region “hubs” supported by the Small Business Technology Transfer (STTR) program.

Velan Capital, L.P. (together with the other members of its group, “Velan” or “we”), one of the largest stockholders of Progenics Pharmaceuticals, Inc. (“Progenics” or the “Company”) (NASDAQ:PGNX), comprised of successful specialty pharmaceutical operators and financial services experts, today released a detailed presentation on Progenics.

Exagen Inc. announced that the Lupus Foundation of America will be recognizing their CEO Ron Rocca at the upcoming Evening of Hope Gala October 28.